Clinical Trial Update: Fixed Dose Combination of Desloratadine / Prednisolone in the Treatment of Moderate Severe Allergic Rhinitis in Children [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a fixed-dose combination of desloratadine and prednisolone for moderate-to-severe allergic rhinitis in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Desloratadine (desloratadine)
• Prednisolone (Prednisolone)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Allergic Rhinitis | Phase 3 | Status: COMPLETED